Gastric cancer: Current status of multimodality treatment;Magenkarzinom: Aktueller Stand der multimodalen Therapie

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 136, Issue 4, 2011, Pages 317-324

  Meyer, H J ^a   Wilke, H ^b  

^a STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

Author keywords

gastric cancer; multimodality treatment; surgical therapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ALGORITHM; ARTICLE; BIOPSY; CANCER INVASION; CANCER STAGING; DIGESTIVE TRACT ENDOSCOPY; GASTRECTOMY; HUMAN; LYMPHADENECTOMY; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS RESECTION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPLENECTOMY; STOMACH TUMOR; SURVIVAL RATE;

ALGORITHMS; BIOPSY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOSCOPY, DIGESTIVE SYSTEM; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPLENECTOMY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 80052184072     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0031-1271580     Document Type: Article

References (45)

1. Kelly J R., Duggan J M. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003 56 1-9 (Pubitemid 36183309)
2. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005 16 481-488 (Pubitemid 40458328)
3. Grundmann R T., Hölscher A H., Bembenek A et al. Diagnostik und Therapie des Magenkarzinoms Workflow. Zentralbl Chir 2009 134 362-374
4. Meyer H-J, Opitz G. Aktuelle chirurgische Therapiestrategien beim Magenkarzinom. Verdauungskrankheiten 2007 25 112-121 (Pubitemid 47024440)
5. Schuhmacher C, Sendler A, Meyer H-J. Chirurgische Therapie des Magenkarzinoms. Onkologe 2008 14 339-349
6. Sant M, Allemani C, Santaquilani M et al. EUROCARE-4: Survival of cancer patients diagnosed in 19951999 Results and commentary. Eur J Cancer 2009 45 931-991
7. Hundahl S A., Phillips J L., Menck H R. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the different disease hypothesis. Cancer 2000 88 921-932 (Pubitemid 30091113)
8. Wilke H, Stahl M. Therapie beim Magenkarzinom Aus onkologischer Sicht. Chirurg 2009 80 1023-1027
9. Lordick F. Prinzipien der neoadjuvanten Therapie. Chirurg 2009 80 1000-1005
10. Dikken J L., Mansen E PM, Cats A et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol 2010 28 2430-2436
11. Ott K, Lordick F. Neoadjuvante Therapie im oberen Gastrointestinaltrakt Magenkarzinom aus chirurgischer Sicht. Chirurg 2009 80 1028-1034
12. Meyer H-J, Opitz G J., Wilke H. Magenkarzinom. Allgemein- und Viszeralchirurgie up2date 2010 6 363-385
13. Englisch-Fritz C, Hünerbein M, Porschen R. Diagnostik beim Magenkarzinom. Onkologe 2008 14 332-338
14. Rabenstein T, Ell C, Feussner H. Endoskopische Resektion und minimal-invasive Verfahren beim Magenkarzinom. Onkologe 2008 14 350-361
15. Gotoda T, Yanagisawa A, Sasako M et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000 3 219-225 (Pubitemid 32290729)
16. Kwee R M., Kwee T C. Imaging in local staging of gastric cancer: A systematic review. J Clin Oncol 2007 25 2107-2116 (Pubitemid 46972798)
17. Beer A J., Wieder H A., Lordick F et al. Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy. Radiology 2006 239 472-480
18. Feussner H, Härtl F. Staginglaparoskopie in der Onkologie. Chirurg 2006 77 971-980 (Pubitemid 44875473)
19. Gemmill E H., McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg 2007 94 1461-1467 (Pubitemid 350275623)
20. Bozzetti F, Marubini E, Bonfanti G et al. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trail. The Italian Gastrointestinal Tumor Study Group. Ann Surg 1997 226 613-620 (Pubitemid 28049657)
21. Gouzi J L., Huguier M, Fagniez P L. et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989 209 162-167
22. Hermanek P. Differenziertes chirurgisches Vorgehen bei der kurativen Therapie des Magenkarzinoms. Leber Magen Darm 1996 26 64-72 (Pubitemid 26121016)
23. Bonenkamp J J., Hermans J, Sasako M et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999 340 908-914 (Pubitemid 29141051)
24. Cuschieri A, Weeden S, Fielding J et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999 79 1522-1530 (Pubitemid 29116815)
25. Hartgrink H H., Jansen E PM, von Grieken N CT et al. Gastric Cancer. Lancet 2009 374 477-490
26. Songun I, Putter H, Meershoek-Klein Kranenbarg E et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010 11 439-449
27. Meyer H-J, Wilke H. Aktueller Stand multimodaler Therapiekonzepte beim Magenkarzinom. Viszeralchirurgie 2001 36 12-19 (Pubitemid 32204124)
28. The GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group. Benefit of adjuvant chemotherapy for resectable gastric cancer. JAMA 2010 303 1729-1737
29. Macdonald J S., Smalley S R., Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001 345 725-730
30. Macdonald J S., Benedetti J, Smalley S et al. Chemoradiation of resected gastric cancer: A 10-year follow-up to the phaseIII trial INT0116 (SWOG 9008). J Clin Oncol 2009 (Abstract 4515)
31. Wilke H, Willich N, Meyer H-J et al. Neoadjuvante und perioperative Therapie des Magenkarzinoms. Onkologe 2008 14 370-380
32. Wilke H, Preusser P, Fink U et al. Preoperative chemotherapy in locally advanced and non-resectable gastric cancer: A phaseII study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 1989 7 1318-1325
33. Plukker J T., Mulder N H., Sleijfer D T. et al. Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5-fluorouracil. Br J Surg 1991 78 995-1001
34. Popiela T, Kulig J, Kolodziejcyk P et al. 20Jahre Erfahrung mit der multimodalen Behandlung von Patienten mit Magenkarzinom in Polen. Zentralbl Chir 2001 126 763-771 (Pubitemid 33031915)
35. Schuhmacher C, Schlag P, Lordick F et al. Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia: Randomized EORTC phaseIII trial #40954. J Clin Oncol 2010 28 5210-5218
36. Cunningham D, Allum W H., Stenning S P. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006 355 11-20
37. Ychou M, Boige V, Pignon J P. et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: An FNCLCC and FFCD multicenter phaseIII trial. J Clin Oncol 2011 29 1715-1721
38. Meyer H-J. The influence of case load and the extent of resection on thequality of treatment outcome in gastric cancer. Eur J Surg Oncol 2005 31 595-604 (Pubitemid 40975241)
39. Siewert J R., Böttcher K, Stein H J. et al. Relevant prognostic factors in gastric cancer. Ten-Year results of the German Gastric Cancer Study. Ann Surg 1998 228 449-461 (Pubitemid 30194389)
40. Napieralski R, Ott K, Kremer M et al. Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: Relation to therapy response and clinicopathologic and molecular features. Clin Cancer Res 2007 13 5095-5102 (Pubitemid 47502076)
41. Ott K, Vogelsang H, Mueller J et al. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma. Clin Cancer Res 2003 9 2307-2315 (Pubitemid 36687657)
42. Weber W A., Ott K, Becker K et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001 19 3058-3065 (Pubitemid 32565444)
43. Lowy A M., Mansfield P F., Leach S D. et al. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 1999 229 303-308 (Pubitemid 30191763)
44. Ott K, Herrmann K, Lordick F et al. Early metabolic response evaluationby fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long term results of a prospective study. Clin Cancer Res 2008 14 2012-2018 (Pubitemid 351551110)
45. Becker K, Mueller J D., Schuhmacher C et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003 98 1521-1530 (Pubitemid 37151509)